Cardiol Therapeutics Inc - Ordinary Shares - Class A Forecast, price target & analysts
$1.41
9.62%
Nasdaq, Oct 02, 04:21 pm EDT.
Closed.
Index
Industry
Cardiol Therapeutics Inc - Ordinary Shares - Class A Target price 2026 - Analyst rating & recommendation
Powered by
Cardiol Therapeutics Inc - Ordinary Shares - Class A Classifications & Recommendation
Buy
88%
Hold
13%
Cardiol Therapeutics Inc - Ordinary Shares - Class A Price Target
| Target Price | $5.18 |
| Price | $1.41 |
| Potential |
267.05%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Cardiol Therapeutics Inc - Ordinary Shares - Class A 2027 .
The average Cardiol Therapeutics Inc - Ordinary Shares - Class A target price is $5.18.
This is
267.05%
register free of charge
$5.53
292.03%
register free of charge
$4.93
249.80%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend Cardiol Therapeutics Inc - Ordinary Shares - Class A to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Cardiol Therapeutics Inc - Ordinary Shares - Class A stock has an average upside potential 2027 of
267.05%
register free of charge
|
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Create a premium account to unlock analyst estimates.
Learn more
Powered by
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| P/E | negative |
6 Analysts have issued a Cardiol Therapeutics Inc - Ordinary Shares - Class A forecast for earnings per share. The average Cardiol Therapeutics Inc - Ordinary Shares - Class A EPS is
$-0.13
unlock
35.00%
higher
unlock
$-0.01
95.00%
unlock
$-0.22
10.00%
unlock
This results in the following potential growth metrics and future valuations:
Cardiol Therapeutics Inc - Ordinary Shares - Class A...
Current Cardiol Therapeutics Inc - Ordinary Shares - Class A Upgrades & Downgrades
Create a Premium account to unlock Upgrades/Downgrades.
Learn more
| Analyst | Rating | Action | Date |
|---|---|---|---|
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| BROOKLINE CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Jul 12 2026 |
| BROOKLINE CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | May 12 2026 |
| BROOKLINE CAPITAL MARKETS |
Locked
➜
Locked
|
Locked | May 11 2026 |
| FIRST BERLIN EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Feb 25 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
BROOKLINE CAPITAL MARKETS:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Jul 12 2026 |
|
Locked
BROOKLINE CAPITAL MARKETS:
Locked
➜
Locked
|
May 12 2026 |
|
Locked
BROOKLINE CAPITAL MARKETS:
Locked
➜
Locked
|
May 11 2026 |
|
Locked
FIRST BERLIN EQUITY RESEARCH:
Locked
➜
Locked
|
Feb 25 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
